BioMedCore, Inc. provides biotechnology development services. It specializes in the research, development, production, and marketing of liposomal technologies. It also develops treatments for cancer, posterior segment inflammatory diseases, and myocardial reperfusion injury. The company was founded by Yuichiro Satoh and Norio Naruse in December 2005 and is headquartered in Yokohama, Japan.

Nanjing Yaoshunyu Biotechnology Co., Ltd., established on 2012-10-19, Business scope includes biotechnology,Medical technology research and development;Quality inspection technical service;Environmental monitoring;Chemical product sales;vocational skills training.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Import and export;Experimental animal production;Aquatic seed production;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;software development;software sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Discovery Genomics, Inc. provides gene therapy tools to cure diseases. It discover gene functions and deliver safe, long-lasting gene therapy. The firm's products include SB Therapeutics Gene Delivery System and Licenses. The company was founded by R. Scott McIvor, Perry B. Hackett, Stephen C. Ekker, and David A. Largaespada in 2000 and is headquartered in Minneapolis, MN.

Suzhou Semico Gene Technology Co., Ltd., established on 2016-04-22, Business scope includes gene technology development,technical consulting,Technical Services,technology transfer;Conference Services;product design;software development;Application software service;Natural science research and experimental development;Medical Research and Experimental Development;Sell ​​self-developed products.Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Boshi Biotechnology Co., Ltd., established on 2017-03-29, The scope of business includes research and development of bio-organic fertilizers;Research and development of biopesticide technology;Research and development of special electronic materials;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Bio-feed R&D;Internet of things technology research and development;R&D and application of cell technology;Research and development of bio-based material polymerization technology;Biochemical product technology research and development;Biomass Energy Technology Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology promotion service;R&D and application of cell technology;Engineering and Technology Research and Experimental Development;internet sales(Except for products that require a license for sale);Asset valuation;Information Technology Consulting Services;Intellectual Property Services;software development;Software outsourcing service;Network and Information Security Software Development;Medical Research and Experimental Development;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Import and export;Food Internet Sales;Health food sales;Health food production

Qingbao (Guangzhou) Biotechnology Co., Ltd., established on 2021-06-08, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biomass Energy Technology Services;Research and development of bio-based materials technology;Standardized service;

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Neofluidics is innovative California-based start-up in the growing field of microfluidics hoping to reinvent the high throughput process with our NeoPlate™ system that drastically reduces the costs of primary drug screening. Using lab-on-a-chip technology integrated into a consumable well plate, the small nanoliter volumes used effect an almost 99% reduction in primary screening costs, while at the same time reducing filling errors and simplifying workflows by allowing single step dilution. The technology has been designed to work with most existing robotic liquid handling systems making its adoption by industry a seamless process. The company has adapted the technology for other applications such as single-cell analysis which features a microfluidic network of trapping chambers designed to capture single cells from a larger, initial cell population which is useful in cancer, immunologic, and genetic research. Another version of the technology uses microscopic volumes for tissue organ modeling to test drug toxicity. Neofluidics is headquartered in Carlsbad, California. Started in 2014, it holds two proprietary patents for lab-on-a-chip technology and has five product lines, including applications in the petroleum and military market segments. Since the launch of our NeoPlate™ well plate in September of 2015, the company has fulfilled orders for numerous clients throughout North America and abroad.

Yihui Technology (Shenzhen) Co., Ltd., established on 2017-12-12, Business scope includes general business items:Class I medical device,R&D and sales of smart devices;Electromechanical equipment and accessories,electronic product,computer,Sales and technical development of computer software and hardware,technical consulting;Health and wellness management consulting(Does not contain medical behavior);Business Management Consulting;Domestic Trade;Operating import and export business.(above laws,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council,Restricted projects must obtain a license before operating),The licensing program is:Class II medical device,R&D and sales of biomedicine;Medical Technology Consulting.

Hangzhou Normal University Affiliated Hospital (doing business as Affiliated Hospital of Hangzhou Normal University), a subsidiary of Hangzhou Normal University, is a Chinese company located in Hangzhou. The firm provides healthcare services.

Shenzhen Juhuatai Technology Co., Ltd., established on 2015-01-15, Business scope includes general business items:Invest in business(Specific projects will be reported separately);investment management(not to engage in trust,Financial Asset Management,Securities asset management and other services);Investment Advisory(No Securities,futures,Insurance and other financial services);Chemical Products,Polymer Materials,R&D and sales of fiber materials and mechanical equipment.,The licensing program is:

Frog Prince (Fujian) Baby & Child Care Products Co., Ltd. engages in the manufacture and sale of baby care and cosmetic products. It offers soaps, detergents, plastic products, disinfection products, toothbrushes, fresheners, fragrances, diapers, baby carriages, baby bottles and pacifiers, wet wipes, paper towels, medical equipment, and medical protective masks. Its business activities include lease of mechanical equipment and property, warehousing services, and research and development of chemical products. The company was founded on October 12, 2017 and is headquartered in Zhangzhou, China.

Shenzhen Tanxi Biotechnology Co., Ltd., established on 2016-02-25, Business scope includes general business items:working in information technology,electronic product,Biotechnology,Chemical Products,Building materials,Equipment,Biological product,Technology development in the field of biotechnology products,technical consulting;Invest in business;Domestic Trade;Operating import and export business(law,Administrative regulations,Except for projects that are required to be approved before registration by decision of the State Council).,The licensing program is:

Shijiazhuang Junlebao Dairy Co., Ltd. engages in the production and sale of dairy products. It operates through the following business segments: Infant milk powder, Low temperature yogurt, normal temperature liquid milk, and Animal husbandry. Its products include cryogenic products such as yogurt, milk cups, cheese, and fermented probiotic milk; room temperature products such as pure milk, flower milk, and lactic acid bacteria drinks; milk powder products; and probiotic products such as probiotic powder. The company was founded in 1995 and is headquartered in Shijiazhuang, China.

Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is a time-honored national high-tech enterprise. In December 1999, the Zhangzhou Pharmaceutical Factory established in 1956 was restructured into Pien Tze Huang Pharmaceutical. In June 2003, the company was listed on the Shanghai Stock Exchange. After two additional issues and one allotment, the company has now issued 603 million shares. Currently, the company has 34 holding subsidiaries, 8 joint -stock companies and 4 industry funds with more than 2,100 employees.

Guangzhou Shanhai Biological Technology Co., Ltd., established on 2020-04-26, Business scope includes drug research and development;Pharmaceutical Research Services;Food Science and Technology Research Services;Medical Research and Experimental Development;Natural science research and experimental development;Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Research and development of biodiagnostic reagents and kits(Does not include license approval items);Sales of biological diagnostic reagents and kits(Does not include license approval items);Biological Products Testing;Water Quality Testing Service;Chemical product testing service;Science and Technology Information Consulting Services;Technology project agency service;Technology project bidding service